Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.38), $0.01 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Dell shares surge on record AI server bookings
• September Stock-Up Season Wraps Up as Yiwugo Merchants Deepen Their Focus on Cold-Weather Essentials
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says